Bu derlemede Korona virüsün böbrek fonksiyonlarına nasıl etkilediğine ve yoğun bakım ünitesinde renal replasman tedavilerine yer verilmiştir.
📌 3 Maddede Bu Makale
🎯
Amaç & Hipotez:Korona virüse (COVİD-19) bağlı mortalitenin artmasına neden olan böbrek yetmezliğinin yoğun bakım sürecinde etkin yönetilmesi hasta sağ kalımı için çok önemlidir.
📊
Temel Bulgular & Veri:Korona virüse (COVİD-19) bağlı mortalitenin artmasına neden olan böbrek yetmezliğinin yoğun bakım sürecinde etkin yönetilmesi hasta sağ kalımı için çok önemlidir.
💡
Sonuç & Katkı:Bu derlemede Korona virüsün böbrek fonksiyonlarına nasıl etkilediğine ve yoğun bakım ünitesinde renal replasman tedavilerine yer verilmiştir.
Korona virüse (COVİD-19) bağlı mortalitenin artmasına neden olan böbrek yetmezliğinin yoğun bakım sürecinde etkin yönetilmesi hasta sağ kalımı için çok önemlidir. Bu derlemede Korona virüsün böbrek fonksiyonlarına nasıl etkilediğine ve yoğun bakım ünitesinde renal replasman tedavilerine yer verilmiştir.
Abstract
Managing renal failure that causes an increase in mortality rates due to coronavirus (Covid-19) effectively during intensive care is of significantly important for survival rates of patients. This review covers how coronavirus affects renal functions and focuses on renal replacement in intensive care units.
Topbaş, E. (2020). COVİD-19 Sürecinde Böbrek Yetmezliği Olan Hastanın Yoğun Bakım Yönetimi. Yoğun Bakım Hemşireliği Dergisi, Cilt: 24 Sayı: EK-1 Özel Sayı, 61–67. https://ajindex.com/articles/1578280
Naicker S, Yang CW, Hwang SJ, Liu BC, Chen JH, Jha V, The novel coronavirus 2019 epidemic and kidneys, Kidney International (2020), doi: https://doi.org/10.1016/ j.kint.2020.03.001.
Fang Z, Fang Y, Wu K, Lai K, Sun X, Zhong N, Liu Z. Clinical characteristics of coronavirus pneumonia 2019 (COVID-19): An updated systematic review. medRxiv doi: https://doi.org/10.
Ronco C, Reis T, De Rosa S. Coronavirus epidemic and extracorporeal therapies in intensive care: si vis pacem para bellum. Blood Purif. 2020;49(3):255-258. doi: 10.1159/000507039.
Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus- ınfected pneumonia in Wuhan, China. JAMA. 2020;323(11):1061–9. doi: 10.1001/jama.2020.1585.
Su H, Yang M, Wan C, Yi LX, Tang F, Zhu HY, et al. Renal histopathological analysis of 26 postmortem findings of patients with COVID-19 in China. Kidney International. 2020. https://doi.org/10.1016/j.kint.2020.04.003.
Zhang YM. & Zhang H. Genetic roadmapfor kidney involvement of severe acute respiratory syndrome coronavirus 2(Sars-Cov-2) İnfection. Clinical Journal of the American Society of Nephrology. 2020:15 Doi: https://doi.org/10.2215/CJN.04370420
The team of Zhong Nanshan responded that the isolation of SARS-CoV-2 from urine remind us to pay more attention to the cleaning of individuals and families. Guangzhou Daily. Published February 22 2020. (Erişim Tarihi: 30.04.2020).
Wang L, Li X, Chen H, Yan S, Li D, Li Y, et al. Coronavirus disease 19 infection does not result in acute kidney injury: an analysis of 116 hospitalized patients from Wuhan, China. American Journal of Nephrology, 2020;51(5):343-348.
Qiu HB, Li XY, Du B, Kang HYJ, Wang YS, Wang F, et al. The keypoints in treatment of the critical novel coronavirus pneumonia patient, Chinese Journal Of Tuberculosis and Respiratory Diseases, 2020;23:43(0):E022. doi: 10.3760/cma.j.cn112147-20200222-00151.
Cheng Y, Luo R, Wang K, Zhang M, Wang Z, Dong L, et al. Kidney disease is associated with in-hospital death of patients with COVID-19. Kidney Int. 2020;97(5):829-838. doi: 10.1016/j.kint.2020.03.005.
Berhés M, Fábián Á, László I, Végh T, Molnár C, Fülesdi B, et al. Organ replacement therapy and life-supporting treatment modalities in critically ill COVID-19 patients. Orv Hetil. 2020;1:161(17):704-709. doi: 10.1556/650.2020.31813.
Bhatraju PK, Ghassemieh BJ, Nichols M, Kim R, Jerome KR, Nalla AK, et al. Covid-19 in Critically Ill Patients in the Seattle Region - Case Series. N Engl J Med. 2020 Mar 30. doi: 10.1056/NEJMoa2004500.
Ali H, Daoud A, Mohamed MM, Salim SA, Yessayan L, Baharani J, et al. Survival rate in acute kidney injury superimposed COVID-19 patients: a systematic review and meta-analysis. Renal Failure, 2020;42(1): 393-397.
Hepokoski ML, Malhotra A, Singh P, Crotty Alexander LE. Ventilator-ınduced kidney ınjury: are novel biomarkers the key to prevention? Nephron. 2018;140(2):90-93. doi: 10.1159/000491557.
Bagshaw SM, Cruz DN, Gibney RT, Ronco C. A proposed algorithm for initiation of renal replacement therapy in adult critically ill patients. Critical care (London, England), 2009;13(6):317. https://doi.org/10.1186/cc8037.
Barbar SD, Clere-JehlR, Bourredjem A, Hernu R, Montini F, Bruyère R. et al. Timing of renal-replacement therapy in patients with acute kidney ınjury and sepsis. N Engl J Med, 2018;379 (15):1431-1442. DOI: 10.1056/NEJMoa1803213.
Al Rifai A, Sukul N,Wonnacott R, Heung M. Safety of arteriovenous fistulae and grafts for continuous renal replacement therapy: The Michigan experience. Hemodialysis International, 2018;22(1):50-55. doi: 10.1111/hdi.12550).
Taniguchi H, Ogawa F, Honzawa H, Yamaguchi K, Niida S, Shinohara M, et al. Veno-venous extracorporeal membrane oxygenation for severe pneumonia: COVID-19 case in Japan. Acute Med Surg. 2020;7(1):e509. doi: 10.1002/ams2.509.
Terzi B. Yoğun bakım ünitesinde hemofiltrasyondaki hastanın hemşirelik bakımı, Nefroloji Hemşireliği Dergisi 2017:(12)1;1-9.
Burgner A, İkizler T.A., Jamie P. Dwyer JP.COVID-19 and the ınpatient dialysis unit managing resources during contingency planning pre-crisis, Clinical Journal of American Society of Nephrology 2020;15 (5):720-722.
Tang B, Li S, Xiong Y, Tian M, Yu J, Xu L, et al. Coronavirus Disease 2019 (COVID-19) Pneumonia in a Hemodialysis Patient. Kidney Med. 2020 Mar 12. doi: 10.1016/j.xkme.2020.03.001.
Alhazzani W, Møller MH, Arabi YM, Loeb M, Gong MN, Fan E, et al. Surviving sepsis campaign: guidelines on the management of critically ill adults with Coronavirus Disease 2019 (COVID-19). Intensive Care Med. 2020 May;46(5):854-887. doi: 10.1007/s00134-020-06022-5.
Alhazzani W, Møller MH, Arabi YM, Loeb M, Gong MN, Fan E, et al. Surviving sepsis campaign: guidelines on the management of critically ill adults with Coronavirus Disease 2019 (COVID-19). Intensive Care Med. 2020 May;46(5):854-887. doi: 10.1007/s00134-020-06022-5.